NOD2 Up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with NOD2 Up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with NOD2 Up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with NOD2 Up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with NOD2 Up.

Results found

Linked to

 

Label

Description

 

Gene

ENSG00000196329 - GTPase, IMAP family member 5

Gene

ENSG00000196418 - zinc finger protein 124

Gene

ENSG00000133063 - chitinase 1

Gene

ENSG00000176533 - G protein subunit gamma 7

Gene

ENSG00000183690 - EF-hand domain containing 2

Gene

ENSG00000102100 - solute carrier family 35 member A2

Gene

ENSG00000173809 - tudor domain containing 12

Gene

ENSG00000156973 - phosphodiesterase 6D

Gene

ENSG00000112303 - vanin 2

Gene

ENSG00000038002 - aspartylglucosaminidase

  • Gene

    ENSG00000196329 - GTPase, IMAP family member 5


  • Gene

    ENSG00000196418 - zinc finger protein 124


  • Gene

    ENSG00000133063 - chitinase 1


  • Gene

    ENSG00000176533 - G protein subunit gamma 7


  • Gene

    ENSG00000183690 - EF-hand domain containing 2


  • Gene

    ENSG00000102100 - solute carrier family 35 member A2


  • Gene

    ENSG00000173809 - tudor domain containing 12


  • Gene

    ENSG00000156973 - phosphodiesterase 6D


  • Gene

    ENSG00000112303 - vanin 2


  • Gene

    ENSG00000038002 - aspartylglucosaminidase

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.